Literature DB >> 14530808

Epstein-Barr virus expression in Hodgkin's lymphoma in Kuwait.

R R Makar1, T Saji, T A Junaid.   

Abstract

The epidemiology of Hodgkin's lymphoma (HL) shows wide geographic variation in histological subtypes and in its association with the Epstein-Barr virus (EBV). The proportion of EBV positive HL is low in industrialized countries, high in non-industrialized countries and intermediate in early-industrialized countries. Reports from the Persian Gulf and Middle East are very limited. The aim of this study was to determine the epidemiology of HL in Kuwait, an early-industrialized country in the Persian Gulf, and to delineate the extent of its association with EBV. We reviewed 134 cases of HL for histological classification and demographic data. 107 cases were examined for the presence of EBV using immunohistochemistry (IHC) for the latent membrane protein I (LMPI) and in-situ hybridization (ISH) for EBVencoded RNA (EBER). 70.4% of the patients were males and 29.6% were females. The male: female ratio was 2.4:1. The mean age was 30.6 years (range, 4-71 years). Mixed cellularity HL (MCHL) was the most common subtype (45.5%), followed by nodular sclerosis (37.3%), nodular lymphocyte predominant (6.7%), lymphocyte rich (3%) and lymphocyte depletion (3%). 4.5% of cases were unclassifiable. EBV expression was seen in 56%, was significantly higher in MCHL, in children, and in males. Our findings suggest that the frequency of EBV expression in HL in Kuwait is similar to other early-industrialized countries. Further research from other countries in the Persian Gulf and the Middle East should shed more light on the epidemiology of HL and its relation to EBV in this region.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530808     DOI: 10.1007/bf03033730

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  28 in total

1.  Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression.

Authors:  M M Morente; M A Piris; V Abraira; A Acevedo; B Aguilera; C Bellas; M Fraga; R Garcia-Del-Moral; F Gomez-Marcos; J Menarguez; H Oliva; M Sanchez-Beato; C Montalban
Journal:  Blood       Date:  1997-09-15       Impact factor: 22.113

2.  Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and Italy.

Authors:  L Leoncini; D Spina; A Nyong'o; O Abinya; C Minacci; A Disanto; F De Luca; A De Vivo; E Sabattini; S Poggi; S Pileri; P Tosi
Journal:  Int J Cancer       Date:  1996-03-15       Impact factor: 7.396

3.  Hodgkin's disease in children in Kuwait.

Authors:  M S Motawy; Y T Omar
Journal:  Cancer       Date:  1986-06-01       Impact factor: 6.860

4.  Adult Hodgkin's disease in Saudi Arabia.

Authors:  T I Mughal; W A Robinson; M A Padmos
Journal:  Eur J Surg Oncol       Date:  1985-03       Impact factor: 4.424

5.  High incidence of Hodgkin's disease in children in Lebanon.

Authors:  S A Azzam
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

6.  The correlation of Epstein-Barr virus expression and lymphocyte subsets with the clinical presentation of nodular sclerosing Hodgkin disease.

Authors:  A Kandil; S Bazarbashi; W A Mourad
Journal:  Cancer       Date:  2001-06-01       Impact factor: 6.860

7.  Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population.

Authors:  G Enblad; K Sandvej; C Sundström; G Pallesen; B Glimelius
Journal:  Acta Oncol       Date:  1999       Impact factor: 4.089

Review 8.  Hodgkin's lymphoma: the pathologist's viewpoint.

Authors:  S A Pileri; S Ascani; L Leoncini; E Sabattini; P L Zinzani; P P Piccaluga; A Pileri; M Giunti; B Falini; G B Bolis; H Stein
Journal:  J Clin Pathol       Date:  2002-03       Impact factor: 3.411

9.  Expression of Epstein-Barr virus in patients with Hodgkin's disease in Taiwan.

Authors:  S M Liu; K C Chow; C F Chiu; C H Tzeng
Journal:  Cancer       Date:  1998-07-15       Impact factor: 6.860

10.  Epstein-Barr virus expression in Hodgkin's disease: Correlation with histologic subtypes and T and B lymphocyte distribution.

Authors:  W Mourad; M O Alsohaibani; M Saddik; S Bazerbashi
Journal:  Ann Saudi Med       Date:  1998 Jul-Aug       Impact factor: 1.526

View more
  8 in total

1.  The high frequency of EBV infection in pediatric Hodgkin lymphoma is related to the classical type in Bahia, Brazil.

Authors:  Iguaracyra Araujo; Achiléa Lisboa Bittencourt; Helenemarie S Barbosa; Eduardo Martins Netto; Núbia Mendonça; Hans-Dieter Foss; Michael Hummel; Harald Stein
Journal:  Virchows Arch       Date:  2006-08-01       Impact factor: 4.064

2.  Epstein-Barr virus and Hodgkin's lymphoma in Cairo, Egypt.

Authors:  Josée Audouin; Jacques Diebold; Bharat Nathwani; Elia Ishak; Kenneth Maclennan; Hans Konrad Mueller-Hermelink; James O Armitage; Dennis D Weisenburger
Journal:  J Hematop       Date:  2010-05-28       Impact factor: 0.196

3.  A collaborative nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses.

Authors:  Zaher K Otrock; Jad Saab; Georges Aftimos; Fady Nasr; Fadi S Farhat; Saad Khairallah; Gérard Abadjian; Marwan Ghosn; Hassan Sidani; Ahmad Ibrahim; Ayman Tawil; Claude Ghorra; Zarouhie Meguerian; Walid Mokaddem; Walid Dayeh; Ziad Salem; Georges Chahine; Nizar Bitar; Anas Mugharbel; Joseph Makdessi; Christina Khater; Mirna El Hajj; Dany Abi Gerges; Charles Sfeir; Joseph Kattan; Khaled Ibrahim; Michel Saade; Hussein Sadek; Rami A Mahfouz; Mohamed A Kharfan-Dabaja; Ghazi Zaatari; Ali Bazarbachi
Journal:  Pathol Oncol Res       Date:  2013-05-08       Impact factor: 3.201

4.  EBV in Hodgkin Lymphoma.

Authors:  Giuseppina Massini; Doerte Siemer; Stefan Hohaus
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-11-24       Impact factor: 2.576

5.  Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar.

Authors:  Maria K Smatti; Hadi M Yassine; Raed AbuOdeh; Asmaa AlMarawani; Sara A Taleb; Asmaa A Althani; Gheyath K Nasrallah
Journal:  PLoS One       Date:  2017-12-11       Impact factor: 3.240

6.  Evidence of EBV infection in lymphomas diagnosed in Lusaka, Zambia.

Authors:  Doris Kafita; Trevor Kaile; Evans Malyangu; Rabecca Tembo; Ephraim Zulu; Chrispin Chisanga; Annie Kalonda; Mulemba Samutela; Pascal Polepole; Geoffrey Kwenda
Journal:  Pan Afr Med J       Date:  2018-03-28

Review 7.  Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.

Authors:  Maria K Smatti; Duaa W Al-Sadeq; Nadima H Ali; Gianfranco Pintus; Haissam Abou-Saleh; Gheyath K Nasrallah
Journal:  Front Oncol       Date:  2018-06-13       Impact factor: 6.244

8.  Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population.

Authors:  Antonio Hugo Jose Froes Marques Campos; Adriana Moreira; Karina Braga Ribeiro; Roberto Pinto Paes; Maria Claudia Zerbini; Vera Aldred; Carmino Antonio de Souza; Cristovam Scapulatempo Neto; Fernando Augusto Soares; Jose Vassallo
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.